Posts Tagged ‘Genentech’

Best Places to Work vs. 100 Best Companies to Work For 2010 – Comparing Glassdoor and Fortune Rankings

Posted by • January 21st, 2010 • 56 Comments

Today Fortune released their list of the “100 Best Companies to Work For 2010”, and we wanted to do a little side by side comparison to see how their list stacks up against Glassdoor’s Best Places to Work. While both lists rely on employee feedback, Glassdoor’s list exclusively represents Employees’ Choice as it takes into account all the anonymous company reviews submitted throughout the year, instead of a short period of time, and does not allow companies to nominate themselves – employees do that through surveys in which they rate and review their employer*.

What we found most interesting was that Glassdoor’s Best Place to Work, Southwest Airlines, was absent from their list, and our #2 slot, General Mills, was ranked #90. It was #1 on our list last year, and barely made Fortune’s rankings at #99. The number one company on Fortune’s listing, SAS, did not make the Best Places to Work top 50 because it had too few reviews to qualify, but it does have a 4.0 rating on Glassdoor, and the CEO, Jim Goodnight, has a 73% approval rating. Fortune’s #2 company, Edward Jones, was also lauded by employees on Glassdoor, however, it was #24 on our list.

Surprisingly ...

Read more »

Tags:
, , , , ,

Roche and Genentech Seal the Deal

Posted by • March 12th, 2009 • Leave a comment

Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn’t already own, ending a long corporate struggle with its U.S.-based cancer drug partner.

A Roche Research Associate commented “Company is losing plenty of talent due to their Genentech offer.”

See what other employees had to say in the days leading up to the final bid.

Roche said its Pharma commercial operations in the U.S. will be moved from Nutley, N.J., to Genentech’s site in South San Francisco, which will become headquarters of the combined company’s U.S. commercial operations in pharmaceuticals and operate under the Genentech name. In addition, Roche stated that research and early development will operate as an independent center within Roche from its existing campus in South San Francisco.

How will employees be impacted with this merger moving forward?

Read more »

Tags:
,

Employees Sound Off on the Future of Genentech: 100% Roche?

Posted by • March 4th, 2009 • 5 Comments

In this week’s news, the future of Genentech crept up as word that Roche, a Swiss drug maker which has owned all or majority parts of Genentech since 1990, was planning on an aggressive bid to take over the company in its entirety – which would account for 44% of Genentech shares it does not already own. In spite of Roche’s significant ownership, Genentech has long been recognized for its independence. Perhaps Genentech’s autonomous corporate attitude is what has led to the success of the company. As you’ll see from the snapshot below that compares Genentech and Roche, Art Levinson’s (CEO of Genentech) noted commitment to science may be just the thing that has led to high employee satisfaction at the workplace, but would this continue if Genentech were to become Roche? Genentech CEO Art Levinson garners 93% approval rating where as Roche CEO Franz Humer receives a low 33% approval rating.

Glassdoor Report: Genentech v. Roche

 
Company Rating
CEO Name
CEO Rating

Genentech
3.9 (Satisfied)
Art Levinson
93%

Roche
3.3 (Neutral) 
Franz B. Humer
33%

Talk about the potential Roche buyout has been in the news for some months now, so it’s no surprise that employees in both camps are talking about the impact this would have – not all positive.

Read more »

Tags:
,

Which CEOs Have Been Naughty or Nice According to Their Employees?

Posted by • December 18th, 2008 • 32 Comments

Yes, that’s right. It’s that time of year where we’re making our list and checking it twice trying to find out which CEO’s rated on Glassdoor.com have been naughty or nice in the eyes of their employees this year.

Genentech‘s Art Levinson comes in as the #1 rated CEO (with at least 50 employees) with a 92% approval rating while and Office Depot‘s Steve Odland is the  least popular CEO with the highest disapproval rating of 80%.

Read more »

Tags:
, , ,